That's a great question.
As for your point, DARPA in the U.S. funds biotechnology that led to the development of RNA vaccines that saved us in the last pandemic.
It's a very broad view of technology development. I would urge this committee to really focus on that.
This is what we're trying to do as a country: to develop technology that will be Canadian-owned and Canadian-developed. It will come from our talent, our researchers, transfer into our companies, be grown here and scaled here. If we don't connect all of these things together.... Sure, we can change the rules of procurement, but at the end, I don't think we'll be able to scale our companies the way we want.
I would really agree with the premise of your question that we have to have a broad portfolio of research. It's not just defence or military use. It's broad use. I would say, in credit to the government, that the 10 capabilities they have put forward seem to be broad enough to have a broad portfolio.